Valiant Organics
VALIANTORG NSE
Valiant Organics
CommoditiesNSE: VALIANTORG BSE: 540145 Chemicals & Petrochemicals
Key Fundamentals
MicrocapSpecialty ChemicalsChemicalsMarket Cap
₹1,015 Cr
Volatility
High Risk
P/E Ratio
22.85
EBITDA
₹87.06 Cr
Return on Equity
-0.47%
Debt to Equity
0.31
Book Value
₹270.88
52W High
₹397
52W Low
₹195
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
2- The company has delivered a poor sales growth of 5.16% over past five years.
- Company has a low return on equity of 0.97% over last 3 years.
Growth Rate
Revenue Growth
1.56% higher than
3Y
Net Income Growth
—
Cash Flow Change
-32.82% higher than
3Y
ROE
-59.13% lower than
3Y
ROCE
248% higher than
3Y
EBITDA Margin (Avg.)
35.24% lower than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 177 | 182 | 141 | 177 | 168 | 160 | 187 | 204 | 204 | 157 | 159 | 218 | 232 |
| Expenses | 156 | 165 | 138 | 179 | 152 | 158 | 172 | 183 | 180 | 136 | 143 | 191 | 190 |
| Operating Profit | 20 | 17 | 4 | -2 | 16 | 2 | 15 | 21 | 25 | 21 | 16 | 26 | 42 |
| OPM % | 11% | 9% | 2.7% | -1% | 9% | 1.5% | 8% | 10% | 12% | 13% | 10% | 12% | 18% |
| Other Income | 6 | 0 | 0 | 2 | 0 | 2 | 5 | 1 | 1 | 0 | 7 | 4 | 3 |
| Interest | 4 | 4 | 4 | 7 | 5 | 8 | 6 | 5 | 6 | 4 | 5 | 3 | 5 |
| Depreciation | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 10 |
| PBT | 14 | 5 | -9 | -16 | 2 | -13 | 6 | 7 | 10 | 7 | 8 | 17 | 29 |
| Tax % | 25% | 26% | -22% | -32% | 118% | -12% | 16% | 44% | 28% | 24% | 27% | 11% | 25% |
| Net Profit | 10 | 4 | -7 | -11 | 0 | -11 | 5 | 4 | 8 | 6 | 6 | 15 | 22 |
| EPS in Rs | 3.82 | 1.44 | -2.43 | -3.86 | -0.16 | -4.04 | 1.68 | 1.41 | 2.71 | 2 | 2.16 | 5.4 | 7.78 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 59 | 52 | 73 | 121 | 606 | 584 | 574 | 948 | 912 | 677 | 719 | 738 | 766 |
| Expenses | 48 | 36 | 55 | 94 | 426 | 410 | 417 | 783 | 782 | 638 | 665 | 650 | 661 |
| Operating Profit | 11 | 16 | 18 | 26 | 179 | 174 | 157 | 165 | 130 | 40 | 54 | 88 | 105 |
| OPM % | 19% | 30% | 25% | 22% | 30% | 30% | 27% | 17% | 14% | 6% | 7% | 12% | 14% |
| Other Income | 1 | 1 | 2 | 1 | 5 | 5 | 17 | 6 | 8 | 9 | 8 | 13 | 14 |
| Interest | 1 | 0 | 0 | 0 | 2 | 1 | 3 | 6 | 11 | 19 | 24 | 18 | 17 |
| Depreciation | 1 | 1 | 2 | 2 | 12 | 13 | 19 | 27 | 28 | 34 | 36 | 40 | 40 |
| PBT | 11 | 16 | 18 | 25 | 171 | 165 | 152 | 137 | 100 | -5 | 2 | 43 | 62 |
| Tax % | 34% | 35% | 35% | 35% | 29% | 25% | 25% | 25% | 24% | -41% | 224% | 20% | — |
| Net Profit | 7 | 10 | 12 | 16 | 121 | 124 | 115 | 103 | 76 | -3 | -3 | 34 | 49 |
| EPS in Rs | 104 | 14.03 | 15.92 | 13.97 | 104 | 51 | 42.2 | 37.91 | 27.83 | -1.1 | -1.07 | 12.26 | 17.34 |
| Div. Payout % | 50% | 71% | 16% | 23% | 6% | 11% | 12% | 9% | 4% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.36 | 4 | 4 | 6 | 6 | 12 | 27 | 27 | 27 | 28 | 28 | 28 |
| Reserves | 21 | 19 | 42 | 53 | 254 | 374 | 475 | 576 | 638 | 637 | 634 | 669 |
| Borrowings | 8 | 1 | 1 | 1 | 53 | 119 | 150 | 306 | 220 | 216 | 212 | 219 |
| Other Liabilities | 11 | 17 | 23 | 36 | 89 | 125 | 154 | 174 | 220 | 262 | 206 | 215 |
| Total Liabilities | 40 | 41 | 69 | 96 | 402 | 629 | 806 | 1,083 | 1,106 | 1,142 | 1,079 | 1,131 |
| Fixed Assets | 11 | 12 | 26 | 31 | 130 | 256 | 478 | 509 | 610 | 630 | 644 | 683 |
| CWIP | 1 | 0 | 0 | 0 | 66 | 129 | 46 | 110 | 70 | 86 | 66 | 21 |
| Investments | 2 | 2 | 7 | 7 | 20 | 34 | 42 | 53 | 53 | 54 | 54 | 64 |
| Other Assets | 26 | 26 | 35 | 58 | 187 | 210 | 240 | 410 | 373 | 371 | 315 | 364 |
| Total Assets | 40 | 41 | 69 | 96 | 402 | 629 | 806 | 1,083 | 1,106 | 1,142 | 1,079 | 1,131 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 6 | 18 | 9 | 18 | 77 | 160 | 115 | -11 | 183 | 85 | 59 | 44 |
| Investing | -1 | -1 | -1 | -6 | -88 | -191 | -135 | -120 | -91 | -65 | -27 | -39 |
| Financing | -5 | -16 | -4 | -5 | 2 | 35 | 22 | 146 | -109 | -23 | -28 | -11 |
| Net Cash Flow | 0 | 0 | 4 | 7 | -8 | 5 | 1 | 14 | -17 | -3 | 4 | -6 |
| Free Cash Flow | 5 | 16 | 5 | 11 | -6 | -42 | -37 | -126 | 96 | 20 | 29 | 11 |
| CFO/OP | 89 | 150 | 87 | 97 | 69 | 115 | 94 | 10 | 154 | 218 | 109 | 47 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 74 | 71 | 88 | 112 | 73 | 69 | 74 | 97 | 85 | 113 | 88 | 120 |
| Inventory Days | 42 | 36 | 97 | 44 | 45 | 47 | 85 | 58 | 69 | 104 | 71 | 76 |
| Days Payable | 7 | 50 | 130 | 154 | 80 | 97 | 135 | 76 | 100 | 189 | 117 | 102 |
| Cash Conversion Cycle | 110 | 57 | 55 | 2 | 37 | 20 | 25 | 80 | 54 | 28 | 43 | 95 |
| Working Capital Days | 53 | 59 | 69 | 41 | 51 | 21 | 4 | 9 | 4 | -7 | -16 | 18 |
| ROCE % | 43% | 61% | 52% | 48% | 91% | 41% | 27% | 18% | 12% | 1% | 3% | 6% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Valiant Organics insights
53 extracted metrics + investor summaries across FY15–FY26.
Documents
1
Announcement under Regulation 30 (LODR)-Newspaper Publication
9 Apr - Newspaper publication regarding Second 100 days Campaign-"Saksham Niveshak" 9 Apr - Newspaper publication regarding Second 100 days Campaign-"Saksham Niveshak"
2
Intimation Regarding Second 100-Days Campaign - ''''Saksham Niveshak''''
6 Apr - Valiant Organics launches IEPFA 'Saksham Niveshak' campaign from Apr 1-Jul 9, 2026 for unpaid dividends and KYC updates. 6 Apr - Valiant Organics launches IEPFA 'Saksham Niveshak' campaign from Apr 1-Jul 9, 2026 for unpaid dividends and KYC updates.
3
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
4 Apr - RTA confirms Regulation 74(5) compliance for quarter and year ended March 31, 2026. 4 Apr - RTA confirms Regulation 74(5) compliance for quarter and year ended March 31, 2026.
4
Closure of Trading Window
26 Mar - Trading window closed from April 1, 2026 until 48 hours after results for quarter/year ended March 31, 2026. 26 Mar - Trading window closed from April 1, 2026 until 48 hours after results for quarter/year ended March 31, 2026.
5
Clarification On Price Movement Of The Security Of The Company.
24 Mar - Valiant Organics clarifies March 24, 2026 price movement; no undisclosed price-sensitive information, market-driven. 24 Mar - Valiant Organics clarifies March 24, 2026 price movement; no undisclosed price-sensitive information, market-driven.
Frequently Asked Questions about Valiant Organics
What does Valiant Organics Ltd do?
Incorporated in 1984, Valiant Organics
Ltd manufactures and deals in specialty chemicals and pharma intermediates[1]
Where is Valiant Organics Ltd (VALIANTORG) listed?
Valiant Organics Ltd trades as VALIANTORG on the NSE and under code 540145 on the BSE.
Which sector does Valiant Organics Ltd belong to?
Valiant Organics Ltd is classified under the Commodities sector, in the Chemicals & Petrochemicals industry.
What is the market capitalisation of Valiant Organics Ltd?
Valiant Organics Ltd has a market capitalisation of ₹1,015 Cr, which places it in the Small Cap band.
What is the PE ratio of Valiant Organics Ltd?
Valiant Organics Ltd trades at a PE ratio of 22.85, against a book value of ₹270.88 per share.
What is the 52-week high and low of Valiant Organics Ltd?
Over the last 52 weeks Valiant Organics Ltd has traded between ₹195 and ₹397.
Does Valiant Organics Ltd pay dividends?
Valiant Organics Ltd has a dividend yield of 0.26%.
What is the Return on Equity (ROE) of Valiant Organics Ltd?
Valiant Organics Ltd reported a return on equity of -0.47%. Its debt-to-equity ratio is 0.31.
Company Information
Incorporated in 1984, Valiant Organics Ltd manufactures and deals in specialty chemicals and pharma intermediates[1]
Website valiantorganics.com
CEO Mr. Sathiababu Krishnan Kallada
Employees 942
Listed 2021-07-23
Face Value ₹ 10
Issued Size 2,76,14,049
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/VALIANTORG.md for Valiant Organics Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.